Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Novartis Pharmaceuticals
Condition: Carcinoid Tumors
NCT00088595
Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: stale_update_signal
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
No stop reason available in the current public record.